Effect of Xuezhikang Therapy on Expression of Pulmonary Hypertension Related miR-638 in Patients With Low HDL-C Levels

• Principais autores: Ruihua Cao (Autor), Tao Sun (Autor), Ruyi Xu (Autor), Jin Zheng (Autor), Hao Wang (Autor), Xiaona Wang (Autor), Yongyi Bai (Autor), Ping Ye (Autor)
• Formato: Livro
• Publicado em: Frontiers Media S.A., 2021-12-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Objective: Low plasma level of high-density lipoprotein cholesterol (HDL-C) associated with poor outcomes in several cardiovascular diseases, including pulmonary arterial hypertension (PAH). Regulation of miR-638 have been proved to be associated with PAH. The aim of this study was to evaluate the e...